1.
Clin Infect Dis
; 43(3): 312-4, 2006 Aug 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16804845
RESUMO
The association between rotavirus serotypes and severity is not well established. Analysis of a clinical trial conducted in Latin America points at more-severe disease associated with serotype G9. Thus, demonstration of efficacy against G9 will be an important asset of any rotavirus vaccine to be introduced into a Latin American country or any country where G9 has been shown to be prevalent.